Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Brain : a journal of neurology

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BRAIN/119.4.1055PMID 8813270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Exchange in the Treatment of Immune Disease

  2003cited by this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy.

  2002influential reference
• Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Intravenous Immunoglobulin

  1998cited by this paper
• Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

  1996cited by this paper
• Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.

  1995cited by this paper
• Immunopathogenesis and treatment of the guillain‐barré syndrome—part I

  1995cited by this paper
• A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy

  1994influential reference
• Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease

  1994cited by this paper
• Delayed apperance of anti–myelin‐associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy

  1993cited by this paper
• Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.

  1993cited by this paper
• Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.

  1993cited by this paper
• Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

  1993cited by this paper
• Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy

  1993cited by this paper
• High‐titer selective serum anti‐β‐tubulin antibodies in chronic inflammatory demyelinating polyneuropathy

  1993cited by this paper
• Subacute idiopathic demyelinating polyradiculoneuropathy.

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

  1992cited by this paper
• The Rochester Diabetic Neuropathy Study

  1992cited by this paper
• T cell responses to myelin proteins in Guillain-Barré syndrome.

  1992cited by this paper
• Electrophysiologic studies in the Guillain–Barré syndrome: Effects of plasma exchange and antibody rebound

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)

  1991cited by this paper
• Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

  1991cited by this paper
• Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

  1991cited by this paper
• Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.

  1991influential reference
• Neuropathy associated with monoclonal gammopathies of undetermined significance

  1991cited by this paper
• Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy.

  1990cited by this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria.

  1989cited by this paper
• Development of myelinated nerve fibers in the sixth cranial nerve of the rat: A quantitative electron microscope study

  1987cited by this paper
• Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy

  1987cited by this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

  1987cited by this paper
• A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies

  1987influential reference
• [Plasma exchange treatment in chronic polyneuritis of the Guillain-Barré type. Experiences with 9 personal cases].

  1986cited by this paper
• Chronic inflammatory demyelinating polyneuropathy of infancy: A corticosteroid‐responsive disorder

  1986cited by this paper
• The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.

  1986cited by this paper
• The utility of therapeutic plasmapheresis for neurological disorders.

  1986cited by this paper
• Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.

  1986cited by this paper
• Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

  1985cited by this paper
• The pathological basis of conduction block in human neuropathies.

  1985cited by this paper
• Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

  1985influential reference
• Chronic demyelinating neuropathy with IgM‐producing lymphocytes in peripheral nerve and delayed appearance of “benign” monoclonal gammopathy

  1984cited by this paper
• Chronic inflammatory polyneuropathy: reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G

  1984cited by this paper
• Reliability and validity of grip and pinch strength evaluations.

  1984cited by this paper
• Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation.

  1983influential reference
• Plasma exchange in chronic inflammatory polyneuropathy: Evidence suggestive of a pathogenic humoral factor

  1982influential reference
• Specificity of plasmapheresis in the treatment of chronic relapsing polyneuropathy.

  1982cited by this paper
• Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

  1982influential reference
• In vivo demyelinating activity of sera from patients with Guillain‐Barré syndrome

  1982cited by this paper
• The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange.

  1981cited by this paper
• Treating chronic relapsing Guillain-Barré syndrome by plasma exchange.

  1979cited by this paper
• Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange

  1979influential reference
• Chronic relapsing polyneuritis.

  1976cited by this paper
• Chronic inflammatory polyradiculoneuropathy.

  1975cited by this paper

• Efgartigimod in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Short Communication

  2026cites this paper
• Treatable Neuropathies.

  2025cites this paper
• Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 procedures

  2025cites this paper
• Innate Immunity in the Pathogenesis of Selected Autoimmune Neurological Diseases

  2025cites this paper
• Therapien für die chronische inflammatorische demyelinisierende Polyneuropathie im Fokus

  2025cites this paper
• CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders

  2025cites this paper
• Autoimmune neuropathies: New guidelines and expert insights into clinical decision making.

  2025cites this paper
• Immunoglobulin unresponsive Guillain-Barré syndrome: rinse or repeat? A systematic review

  2025cites this paper
• Key considerations in setting up a therapeutic plasma exchange service for neurology patients 

  2025cites this paper
• A pathophysiological and mechanistic review of chronic inflammatory demyelinating polyradiculoneuropathy therapy

  2025cites this paper
• Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11‐year report from a tertiary care center

  2024cites this paper
• Polirradiculoneuritis adquiridas agudas y crónicas en la infancia

  2024cites this paper
• Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives

  2024cites this paper
• Therapy-resistant autoimmune nodopathy with anti-neurofascin 155 antibodies: a case report

  2024cites this paper
• Long-term follow-up of relapse and remission of CIDP in a Chinese cohort

  2024cites this paper
• Treatment response in patients with clinical and supportive laboratory features of chronic inflammatory demyelinating polyneuropathy without demyelinative findings on nerve conduction studies: A retrospective study

  2024cites this paper
• Correlation of single-fiber electromyography studies and functional status in patients with amyotrophic lateral sclerosis

  2024cites this paper
• Outcomes of therapeutic plasma exchange: A 15-year tertiary center experience

  2023cites this paper
• Polyradiculonévrites acquises aiguës et chroniques de l’enfant

  2023cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

  2023cites this paper
• A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States

  2023cites this paper
• Plasmapheresis in the ICU

  2023cites this paper
• Dose–Effect Relationship of Motor Nerve Inexcitability on Outcome in Guillain–Barré Syndrome: A Prospective Cohort Study

  2023cites this paper
• Acute/chronic inflammatory polyradiculoneuropathy.

  2023cites this paper
• Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept

  2022cites this paper
• Treatment of CIDP

  2022cites this paper
• Prognostic Significance of Serial Nerve Conduction in GB Syndrome.

  2022cites this paper
• French recommendations for the management of adult & pediatric chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

  2022cites this paper
• Treatment and Management of Autoimmune Neuropathies

  2022cites this paper
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.

  2022cites this paper
• IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies

  2022cites this paper
• 11 (2) January 2022 n.surg..pmd

  2022cites this paper
• Neuromuscular Complications of General Medical Disorders

  2021cites this paper
• European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

  2021cites this paper
• Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP

  2021cites this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy – a narrative review Polineuropatia desmielinizante inflamatória crônica – uma revisão narrativa

  2021cites this paper
• Recovery of foot drop in chronic inflammatory demyelinating polyneuropathy (CIDP)

  2021cites this paper
• Estimation of the latent therapeutic demand for immunoglobulin therapies in autoimmune neuropathies in the United States

  2021cites this paper
• European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

  2021cites this paper
• Polineuropatia desmielinizante inflamatória crônica – uma revisão narrativa

  2021cites this paper
• Therapeutic plasma exchange in neuroimmunologic disease: 60 patients experience

  2021cites this paper
• Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies

  2020cites this paper
• Therapien bei der chronisch inflammatorischen demyelinisierenden Polyneuropathie

  2020cites this paper
• Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions

  2020cites this paper
• Inflammatory polyradiculoneuropathies: Clinical and immunological aspects, current therapies, and future perspectives

  2020cites this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy—Diagnostic pitfalls and treatment approach

  2020cites this paper
• Progress in Hematopoietic Stem Cell Transplantation for CIDP

  2020cites this paper
• Plasmapheresis for Multiple Sclerosis in the Twenty-First Century: Take It or Leave It?

  2020cites this paper
• Peripheral Neuropathies

  2020cites this paper
• Rituximab in refractory chronic inflammatory demyelinating polyneuropathy

  2020cites this paper
• ERKRANKUNGEN DER NIERE

  2020cites this paper
• Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barré Syndrome.

  2020cites this paper
• Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

  2020cites this paper
• Therapeutic plasma exchange - A brief review of indications, urgency, schedule, and technical aspects.

  2019cites this paper
• Introduction to therapeutic plasma exchange.

  2019cites this paper
• Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment

  2019cites this paper
• Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence.

  2019cites this paper
• Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.

  2019cites this paper
• The Effect Of Nursing Application Of Neuromuscular Electrical Stimulation on Mechanically Ventilated Patient's Outcome

  2019cites this paper
• Existing and Emerging Approaches to Treating Chronic Inflammatory Demyelinating Polyneuropathy

  2019cites this paper
• Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Traditional agents

  2019cites this paper
• СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О ЛЕЧЕНИИ ХРОНИЧЕСКОЙ ВОСПАЛИТЕЛЬНОЙ ДЕМИЕЛИНИЗИРУЮЩЕЙ ПОЛИНЕЙРОПАТИИ (обзор литературы)

  2019cites this paper
• Polineuropatía desmielinizante inflamatoria crónica: revisión a propósito de un caso

  2019cites this paper
• Konsensuspapier zum Einsatz der therapeutischen Apherese in der Neurologie

  2019cites this paper
• Outcome measures for chronic inflammatory demyelinating polyneuropathy in research: relevance and applicability to clinical practice.

  2019cites this paper
• THERAPEUTIC PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN SEVERE NEUROIMMUNE DISORDERS

  2019cites this paper
• AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)

  2019cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cites this paper
• Plasma exchange in neurological disease

  2019cites this paper
• Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.

  2019influential citation
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  2019cites this paper
• Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

  2019cites this paper
• Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience

  2018cites this paper
• History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  2018cites this paper
• Mechanism and spectrum of anti‐glycolipid antibody‐mediated chronic inflammatory demyelinating polyneuropathy

  2018cites this paper
• Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression

  2018cites this paper
• IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety

  2018cites this paper
• Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

  2017cites this paper
• Chronic inflammatory demyelinating polyneuropathy presenting with autonomic symptoms: a case report

  2017cites this paper
• Prospective comparison of AMAN and AIDP in 140 children with Guillain-Barr é syndrome in India

  2017cites this paper
• Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain–Barré syndrome in India

  2017cites this paper
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy 101—Pitfalls and Pearls of Diagnosis and Treatment

  2017cites this paper
• Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

  2017cites this paper
• Therapeutic plasma exchange in neuro-immunological disorder

  2017cites this paper
• The Immunomodulatory Role of Therapeutic Plasma Exchange in Peripheral Nervous System and Neuromuscular Diseases

  2017cites this paper
• The role of human natural killer-1 (HNK-1) carbohydrate in neuronal plasticity and disease.

  2017cites this paper
• Two years’ long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment

  2017cites this paper
• Therapeutic plasma exchange in chronic dysimmune peripheral neuropathies: A 10‐year retrospective study

  2017cites this paper
• Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases

  2017cites this paper
• Therapeutic Advances in Neurological Disorders

  2017cites this paper
• Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan

  2017cites this paper
• Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.

  2017cites this paper
• Immunopathogenesis and Treatment of Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy

  2017cites this paper
• Existe-t-il des facteurs prédictifs d'efficacité des immunoglobulines intraveineuses au cours des PIDC ? À propos d'une cohorte amiénoise de 27 patients

  2016cites this paper
• [Chronic Inflammatory Demyelinating Polyneuropathy].

  2016cites this paper
• Modified Atkins diet induces subacute selective ragged‐red‐fiber lysis in mitochondrial myopathy patients

  2016cites this paper
• Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.

  2016cites this paper
• Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation

  2016cites this paper
• Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.

  2016cites this paper
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.

  2016cites this paper